Skip to main content

Table 3 Association of chronic kidney disease and apo-lipoprotein B in study subjects stratified by age, gender, body mass index and hyperuricemia

From: Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey

CharactersOdds Ratio (95% CIa)
Model 1bModel 2bModel 3bModel 4bModel 5b
Age Groups
 18–401.53 (1.33,1.77)1.59 (1.37,1.84)1.50 (1.29,1.75)1.41 (1.11,1.79)1.37 (1.08,1.7)
 40–651.57 (1.44,1.73)1.59 (1.37,1.84)1.51 (1.37,1.66)1.30 (1.11,1.53)1.32 (1.12,1.55)
  > 651.28 (1.12,1.47)1.19 (1.03,1.37)1.14 (0.99,1.33)1.14 (0.87,1.49)1.18 (0.90,1.55)
Gender
 Female2.03 (1.86,2.22)1.45 (1.32,1.60)1.36 (1.23,1.50)1.13 (0.96,1.35)1.14 (0.96,1.36)
 Male1.55 (1.42,1.70)1.49 (1.35,1.65)1.42 (1.28,1.57)1.41 (1.20,1.66)1.41 (1.20,1.67)
Body Mass Index
  < =251.79 (1.66,1.94)1.48 (1.37,1.61)1.37 (1.25,1.49)1.15 (0.99,1.34)1.16 (0.99,1.34)
  > 251.74 (1.55,1.94)1.51 (1.35,1.70)1.45 (1.28,1.63)1.60 (1.31,1.96)1.62 (1.32,1.99)
Hyperuricemia
 Yes1.43 (1.25,1.64)1.38 (1.19,1.59)1.40 (1.21,1.63)1.50 (1.16,1.93)1.52 (1.18,1.97)
 No1.75 (1.63,1.88)1.42 (1.31,1.45)1.39 (1.29,1.51)1.19 (1.04,1.36)1.19 (1.04,1.37)
  1. aCI Confidence interval
  2. bAdjusted for the same model as Table 2 except the variable that are stratified